These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 34318743

  • 1. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
    Wu O, McCartney E, Heggie R, Germeni E, Paul J, Soulis E, Dillon S, Ryan C, Sim M, Dixon-Hughes J, Agarwal R, Bodenham A, Menne T, Jones B, Moss J.
    Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
    [Abstract] [Full Text] [Related]

  • 2. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial.
    Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL, Heggie R, Hill S, Dixon-Hughes J, Soulis E, Germeni E, Dillon S, McCartney E, CAVA trial group.
    Lancet; 2021 Jul 31; 398(10298):403-415. PubMed ID: 34297997
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R, Brown M, Faria R, Fraser C, Donohue C, Rainford N, Grosso A, Sinha AK, Dorling J, Gray J, Muller-Pebody B, Harron K, Moitt T, McGuire W, Bojke L, Gamble C, Oddie SJ.
    Health Technol Assess; 2020 Nov 31; 24(57):1-190. PubMed ID: 33174528
    [Abstract] [Full Text] [Related]

  • 4. Patient acceptability of three different central venous access devices for the delivery of systemic anticancer therapy: a qualitative study.
    Ryan C, Hesselgreaves H, Wu O, Moss J, Paul J, Dixon-Hughes J, Germeni E.
    BMJ Open; 2019 Jul 09; 9(7):e026077. PubMed ID: 31292176
    [Abstract] [Full Text] [Related]

  • 5. Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review.
    Wang K, Zhong J, Huang N, Zhou Y.
    J Vasc Access; 2020 Nov 09; 21(6):826-837. PubMed ID: 31894710
    [Abstract] [Full Text] [Related]

  • 6. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE.
    Health Technol Assess; 2021 Dec 09; 25(75):1-134. PubMed ID: 34931602
    [Abstract] [Full Text] [Related]

  • 7. Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.
    Dasgupta R, Cameron S, Aucott L, MacLennan G, Kilonzo MM, Lam TB, Thomas R, Norrie J, McDonald A, Anson K, N'Dow J, Burgess N, Clark CT, Keeley FX, MacLennan SJ, Starr K, McClinton S.
    Health Technol Assess; 2022 Mar 09; 26(19):1-70. PubMed ID: 35301982
    [Abstract] [Full Text] [Related]

  • 8. Peripherally inserted central catheter versus totally implanted venous port for delivering medium- to long-term chemotherapy: A cost-effectiveness analysis based on propensity score matching.
    Wang K, Zhou Y, Huang N, Lu Z, Zhang X.
    J Vasc Access; 2022 May 09; 23(3):365-374. PubMed ID: 33579176
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.
    Taxbro K, Hammarskjöld F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S.
    Br J Anaesth; 2019 Jun 09; 122(6):734-741. PubMed ID: 31005243
    [Abstract] [Full Text] [Related]

  • 10. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: the HEALTH RCT.
    Cooper K, Breeman S, Scott NW, Scotland G, Hernández R, Clark TJ, Hawe J, Hawthorn R, Phillips K, Wileman S, McCormack K, Norrie J, Bhattacharya S.
    Health Technol Assess; 2019 Sep 09; 23(53):1-108. PubMed ID: 31577219
    [Abstract] [Full Text] [Related]

  • 11. 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
    Iveson T, Boyd KA, Kerr RS, Robles-Zurita J, Saunders MP, Briggs AH, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan H, Paul J.
    Health Technol Assess; 2019 Dec 09; 23(64):1-88. PubMed ID: 31852579
    [Abstract] [Full Text] [Related]

  • 12. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH, Robinson EJ, Pilecka I, Perdue I, Mosweu I, Read J, Jordan H, Wilkinson M, Rawlings G, Feehan SJ, Callaghan H, Day E, Purnell J, Baldellou Lopez M, Brockington A, Burness C, Poole NA, Eastwood C, Moore M, Mellers JD, Stone J, Carson A, Medford N, Reuber M, McCrone P, Murray J, Richardson MP, Landau S, Chalder T.
    Health Technol Assess; 2021 Jun 09; 25(43):1-144. PubMed ID: 34196269
    [Abstract] [Full Text] [Related]

  • 13. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
    Constable L, Abrams P, Cooper D, Kilonzo M, Cotterill N, Harding C, Drake MJ, Pardoe MN, McDonald A, Smith R, Norrie J, McCormack K, Ramsay C, Uren A, Mundy T, Glazener C, MacLennan G.
    Health Technol Assess; 2022 Aug 09; 26(36):1-152. PubMed ID: 35972773
    [Abstract] [Full Text] [Related]

  • 14. Cost-utility analysis of centrally inserted totally implanted access port (PORT) vs. peripherally inserted central catheter (PICC) in the oncology chemotherapy.
    Shao G, Zhou X, Zhang S, Wu S, Dong Y, Dong Z.
    Front Public Health; 2022 Aug 09; 10():942175. PubMed ID: 35937250
    [Abstract] [Full Text] [Related]

  • 15. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
    Clarkson JE, Pitts NB, Goulao B, Boyers D, Ramsay CR, Floate R, Braid HJ, Fee PA, Ord FS, Worthington HV, van der Pol M, Young L, Freeman R, Gouick J, Humphris GM, Mitchell FE, McDonald AM, Norrie JD, Sim K, Douglas G, Ricketts D.
    Health Technol Assess; 2020 Nov 09; 24(60):1-138. PubMed ID: 33215986
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.
    Hykin P, Prevost AT, Sivaprasad S, Vasconcelos JC, Murphy C, Kelly J, Ramu J, Alshreef A, Flight L, Pennington R, Hounsome B, Lever E, Metry A, Poku E, Yang Y, Harding SP, Lotery A, Chakravarthy U, Brazier J.
    Health Technol Assess; 2021 Jun 09; 25(38):1-196. PubMed ID: 34132192
    [Abstract] [Full Text] [Related]

  • 17. Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
    Collinson F, Royle KL, Swain J, Ralph C, Maraveyas A, Eisen T, Nathan P, Jones R, Meads D, Min Wah T, Martin A, Bestall J, Kelly-Morland C, Linsley C, Oughton J, Chan K, Theodoulou E, Arias-Pinilla G, Kwan A, Daverede L, Handforth C, Trainor S, Salawu A, McCabe C, Goh V, Buckley D, Hewison J, Gregory W, Selby P, Brown J, Brown J, all the STAR investigators.
    Health Technol Assess; 2024 Aug 09; 28(45):1-171. PubMed ID: 39250424
    [Abstract] [Full Text] [Related]

  • 18. Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCT.
    Benger JR, Kirby K, Black S, Brett SJ, Clout M, Lazaroo MJ, Nolan JP, Reeves BC, Robinson M, Scott LJ, Smartt H, South A, Stokes EA, Taylor J, Thomas M, Voss S, Wordsworth S, Rogers CA.
    Health Technol Assess; 2022 Apr 09; 26(21):1-158. PubMed ID: 35426781
    [Abstract] [Full Text] [Related]

  • 19. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
    Bertoglio S, Cafiero F, Meszaros P, Varaldo E, Blondeaux E, Molinelli C, Minuto M.
    J Vasc Access; 2020 Jul 09; 21(4):460-466. PubMed ID: 31674857
    [Abstract] [Full Text] [Related]

  • 20. Early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration: the EVRA RCT.
    Gohel MS, Heatley F, Liu X, Bradbury A, Bulbulia R, Cullum N, Epstein DM, Nyamekye I, Poskitt KR, Renton S, Warwick J, Davies AH.
    Health Technol Assess; 2019 May 09; 23(24):1-96. PubMed ID: 31140402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.